Cargando…
188P Efficacy of SARS-CoV-2 based mRNA vaccines for patients with thoracic malignancies with 6 months follow up: A prospective observational study
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976192/ http://dx.doi.org/10.1016/j.annonc.2022.02.113 |
| _version_ | 1784680511409487872 |
|---|---|
| author | Janzic, U. Mohorcic, K. Mrak, L. Ivanovic, M. Bidovec Stojkovic, U. Debeljak, J. Korosec, P. Rijavec, M. |
| author_facet | Janzic, U. Mohorcic, K. Mrak, L. Ivanovic, M. Bidovec Stojkovic, U. Debeljak, J. Korosec, P. Rijavec, M. |
| author_sort | Janzic, U. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8976192 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89761922022-04-04 188P Efficacy of SARS-CoV-2 based mRNA vaccines for patients with thoracic malignancies with 6 months follow up: A prospective observational study Janzic, U. Mohorcic, K. Mrak, L. Ivanovic, M. Bidovec Stojkovic, U. Debeljak, J. Korosec, P. Rijavec, M. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2022-04 2022-04-02 /pmc/articles/PMC8976192/ http://dx.doi.org/10.1016/j.annonc.2022.02.113 Text en Copyright © 2022 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Janzic, U. Mohorcic, K. Mrak, L. Ivanovic, M. Bidovec Stojkovic, U. Debeljak, J. Korosec, P. Rijavec, M. 188P Efficacy of SARS-CoV-2 based mRNA vaccines for patients with thoracic malignancies with 6 months follow up: A prospective observational study |
| title | 188P Efficacy of SARS-CoV-2 based mRNA vaccines for patients with thoracic malignancies with 6 months follow up: A prospective observational study |
| title_full | 188P Efficacy of SARS-CoV-2 based mRNA vaccines for patients with thoracic malignancies with 6 months follow up: A prospective observational study |
| title_fullStr | 188P Efficacy of SARS-CoV-2 based mRNA vaccines for patients with thoracic malignancies with 6 months follow up: A prospective observational study |
| title_full_unstemmed | 188P Efficacy of SARS-CoV-2 based mRNA vaccines for patients with thoracic malignancies with 6 months follow up: A prospective observational study |
| title_short | 188P Efficacy of SARS-CoV-2 based mRNA vaccines for patients with thoracic malignancies with 6 months follow up: A prospective observational study |
| title_sort | 188p efficacy of sars-cov-2 based mrna vaccines for patients with thoracic malignancies with 6 months follow up: a prospective observational study |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976192/ http://dx.doi.org/10.1016/j.annonc.2022.02.113 |
| work_keys_str_mv | AT janzicu 188pefficacyofsarscov2basedmrnavaccinesforpatientswiththoracicmalignancieswith6monthsfollowupaprospectiveobservationalstudy AT mohorcick 188pefficacyofsarscov2basedmrnavaccinesforpatientswiththoracicmalignancieswith6monthsfollowupaprospectiveobservationalstudy AT mrakl 188pefficacyofsarscov2basedmrnavaccinesforpatientswiththoracicmalignancieswith6monthsfollowupaprospectiveobservationalstudy AT ivanovicm 188pefficacyofsarscov2basedmrnavaccinesforpatientswiththoracicmalignancieswith6monthsfollowupaprospectiveobservationalstudy AT bidovecstojkovicu 188pefficacyofsarscov2basedmrnavaccinesforpatientswiththoracicmalignancieswith6monthsfollowupaprospectiveobservationalstudy AT debeljakj 188pefficacyofsarscov2basedmrnavaccinesforpatientswiththoracicmalignancieswith6monthsfollowupaprospectiveobservationalstudy AT korosecp 188pefficacyofsarscov2basedmrnavaccinesforpatientswiththoracicmalignancieswith6monthsfollowupaprospectiveobservationalstudy AT rijavecm 188pefficacyofsarscov2basedmrnavaccinesforpatientswiththoracicmalignancieswith6monthsfollowupaprospectiveobservationalstudy |